Company Search:
Advanced Search
Sponsored Links
Protek PAO Company Snapshot
Protek PAO operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Protek PAO with three other pharmaceutical manufacturers in Europe: H. Lundbeck A/S of Denmark (2018 sales of 18.12 billion Danish Kroner [US$2.69 billion] of which 100% was Pharmaceuticals), Ipsen SA of France (2.35 billion Euro [US$2.60 billion] of which 82% was Specialty Care), and Stada Arzneimittel AG which is based in Germany (2.33 billion Euro [US$2.58 billion] of which 59% was Generics).

Sales Analysis. During the year ended December of 2018, sales at Protek PAO were 251.73 billion Russian Rubles (US$3.95 billion). This is a decrease of 2.6% versus 2017, when the company's sales were 258.45 billion Russian Rubles. Contributing to the drop in overall sales was the 9.5% decline in Distribution, from 201.43 billion Russian Rubles to 182.35 billion Russian Rubles. . However, these declines were partially offset by the increase in sales of Retail Sales (up 23.6% to 61.53 billion Russian Rubles) and Production (up 8.0% to 7.86 billion Russian Rubles) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Protek PAO
  Stock Performance Chart for Protek PAO
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 93.50
(Figures in Russian Rubles)
1 Week 0.5%   13 Weeks 0.0%  
4 Weeks 0.5%   52 Weeks 17.6%  
Protek PAO Key Data:
  Ticker: PRTK Country: Russian Federation
  Exchanges: RTS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2018 Sales 251,733,446,000
(Year Ending Jan 2019).
Employees: 17,050
  Currency: Russian Rubles Market Cap: 49,287,857,130
  Fiscal Yr Ends: December Shares Outstanding: 527,142,857
  Share Type: Closely Held Shares: 440,533,286
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.